DrugPatentWatch Database Preview
AUSTEDO Drug Profile
Which patents cover Austedo, and what generic alternatives are available?
Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. There are five patents protecting this drug.
This drug has twenty-nine patent family members in eleven countries.
The generic ingredient in AUSTEDO is deutetrabenazine. One supplier is listed for this compound. Additional details are available on the deutetrabenazine profile page.
Summary for AUSTEDO
| International Patents: | 29 |
| US Patents: | 5 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 11 |
| Patent Applications: | 6 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for AUSTEDO |
| DailyMed Link: | AUSTEDO at DailyMed |
Generic Entry Opportunity Date for AUSTEDO
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for AUSTEDO
| (3R,11bR)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one |
| (3RS,11Brs)-9,10-di((2H3)methoxy)-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-benzo(a)quinolizin-2-one |
| [2H6]-(+)-Tetrabenazine|||[2H6]-(+)- 9,10-Dimethoxy-1,3R,4,6,7,11bR-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one |
| 1392826-25-3 |
| 2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)-, (3R,11bR)-rel- |
| CHEMBL3137326 |
| D10701 |
| DB12161 |
| Deutetrabenazine |
| Deutetrabenazine (USAN/INN) |
| Deutetrabenazine [USAN:INN] |
| Dutetrabenazine |
| GTPL8707 |
| HY-B0590S |
| Ro 1-9569 D6 |
| SCHEMBL13321841 |
| SCHEMBL16227993 |
| SCHEMBL16228022 |
| SD 809 |
| SD-809 |
| SD809 |
| Tetrabenazine D6 |
| UNII-P341G6W9NB component MKJIEFSOBYUXJB-VFJJUKLQSA-N |
| UNII-P341G6W9NB component MKJIEFSOBYUXJB-WEZHFFAMSA-N |
US Patents and Regulatory Information for AUSTEDO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-001 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-002 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-001 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-001 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-002 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-003 | Apr 3, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for AUSTEDO
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 104684555 | ➤ Sign Up |
| New Zealand | 591615 | ➤ Sign Up |
| Canada | 2972242 | ➤ Sign Up |
| Japan | 2015007124 | ➤ Sign Up |
| Hong Kong | 1212232 | ➤ Sign Up |
| Canada | 2736409 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
